The diagnostic market is at a moment of change. New approaches, such as sequencing, are gaining traction; companion diagnostics are driving closer integration with therapy; continuous monitoring is enabling new diagnostic information; and market drivers are demanding low cost distribution of clinical quality data.
Bespoke diagnostics development service
At TTP we bring together world-leading scientists and engineers to deliver cutting-edge diagnostics solutions today – and we have done so for over three decades. We have a proven track record of working at the forefront of technology, inventing disruptive diagnostic systems every day.
We integrate complex processes into easy-to-use and low-cost disposables. We offer clients complementary technologies that ensure they can deliver. We are unrivalled in speed of development, confidence of functionality and of regulatory manufacturability – and we can deliver at scale.
We make sure diagnostics solutions of the future are delivered today.
We provide workable solutions to the most challenging diagnostics problems; turning complex lab processes into simple-to-use diagnostics.
Our interdisciplinary expert biologists and chemists work in consort with engineers, physicists and human factors to rapidly transform initial ideas into marketable products, and invent new technologies, approaches and platforms.
We partner with you to achieve a shared goal, focusing on outcomes and added-value through our pragmatic and creative approach.
Rapid prototyping and system testing has always been a key aspect of TTP’s development services. Functional testing and often assay evolution are undertaken throughout.
From engineering facilities to molecular biology and class II, cell culture and bioengineering labs to a MEMS cleanroom, we invest in world-class facilities and maintain ISO 13485:2016 accreditation.
Independent Technology Development
We offer clients complementary technologies such as communications and algorithm developments. We also regularly develop technologies that can be customised and used by our clients in the diagnostic market.
Concept generation, functional specification, ID, HF
Workflow integration, microfluidics, modelling, production insight
Assay design, refinement, new reagent development
Integrated system and SW development
Cartridge and instrumentation, control, algorithms, UI
Testing, refinement integration
Established prototyping facilities to enable instruments and cartridges at medium volumes (up to 100s of instruments and 1000s of cartridges)
Design for manufacture
We can design your system or integrate with other internal or external design partners.
Manufacturing line development
Support in selection, line creation, and knowledge and design transfer for all scales of manufacture.
Structured and effective risk management as part of our QMS. ISO13485:2016 accredited and documentation delivery.
A new era in point-of-care diagnostic testing: possibilities and practicalities
Healthcare systems are under pressure from a multiplicity of sometimes confounding factors, such as increasing backlogs created by the COVID-19 pandemic, staff shortages, changing population demographics, rising prevalence of chronic diseases, and the spread of infectious diseases.
For the situation to improve, there needs to be a rethinking of the approach to healthcare management and practices, including how broader use of in vitro diagnostic point-of-care (IVD POC) testing could be used to help better inform treatment decision-making in the acute setting.
To better understand the scope for increased adoption and expansion of POC testing beyond what is currently available, TTP commissioned a survey of UK and US emergency department (ED) based healthcare professionals (HCPs), specifically doctors, nurses, and paramedics.
In this report, we present the survey’s key findings and examine the opportunities and important considerations for IVD POC testing in the United Kingdom and the United States – within the ED as well as the wider community setting.